• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科人群中的扩张型心肌病:病因及预后预测因素——单中心经验

Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.

作者信息

Ciuca Cristina, Ragni Luca, Hasan Tammam, Balducci Anna, Angeli Emanuela, Prandstraller Daniela, Egidy-Assenza Gabriele, Donti Andrea, Bonvicini Marco, Gargiulo Gaetano D

机构信息

Pediatric Cardiology & GUCH Unit, Cardiothoracic-Vascular Department, University Hospital S. Orsola-Malpighi, Bologna, 40138, Italy.

Pediatric & Grown-up Congenital Cardiac Surgery Unit, Cardiothoracic-Vascular Department, University Hospital S. Orsola-Malpighi, Bologna, 40138, Italy.

出版信息

Future Cardiol. 2019 Mar;15(2):95-107. doi: 10.2217/fca-2018-0030. Epub 2019 Mar 8.

DOI:10.2217/fca-2018-0030
PMID:30848673
Abstract

AIM

The aim of the study was to assess predictors of outcome in patients hospitalized for dilated cardiomyopathy (DCM) and severe left ventricular dysfunction. Patients & methods: 83 pediatric patients hospitalized for heart failure due to DCM with coexistent left ventricular dysfunction were enrolled.

RESULTS

Overall, 5-year survival free from heart transplantation was 69.8%. Normalization of left ventricular function was achieved in 39.8% of patients during follow-up: younger age, less necessity of inotropic support and other than idiopathic DCM predicted left ventricular function, while familial history for cardiac disease or sudden death and inotropic support during hospitalization were associated with poorer outcome.

CONCLUSION

Almost 40% of patients with DCM experienced a complete normalization of cardiac function. Outcome was extremely variable according to the type of DCM.

摘要

目的

本研究旨在评估因扩张型心肌病(DCM)和严重左心室功能不全住院患者的预后预测因素。患者与方法:纳入83例因DCM合并左心室功能不全而住院治疗心力衰竭的儿科患者。

结果

总体而言,无心脏移植的5年生存率为69.8%。随访期间39.8%的患者左心室功能恢复正常:年龄较小、较少需要使用正性肌力药物支持以及非特发性DCM可预测左心室功能,而心脏病家族史或猝死家族史以及住院期间使用正性肌力药物支持与较差的预后相关。

结论

近40%的DCM患者心脏功能完全恢复正常。根据DCM的类型,预后差异极大。

相似文献

1
Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.儿科人群中的扩张型心肌病:病因及预后预测因素——单中心经验
Future Cardiol. 2019 Mar;15(2):95-107. doi: 10.2217/fca-2018-0030. Epub 2019 Mar 8.
2
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.蒽环类药物相关性与特发性扩张型心肌病患者长期预后的比较:单中心经验。
Eur J Heart Fail. 2018 May;20(5):898-906. doi: 10.1002/ejhf.1049. Epub 2017 Nov 16.
3
Natural History of Dilated Cardiomyopathy in Children.儿童扩张型心肌病的自然病史
J Am Heart Assoc. 2016 Jun 30;5(7):e003450. doi: 10.1161/JAHA.116.003450.
4
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.特发性扩张型心肌病患儿超声心动图功能的恢复:儿科心肌病注册研究结果。
J Am Coll Cardiol. 2014 Apr 15;63(14):1405-13. doi: 10.1016/j.jacc.2013.11.059. Epub 2014 Feb 19.
5
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction.扩张型心肌病伴中间左心室功能障碍患者的心律失常风险分层。
J Cardiovasc Med (Hagerstown). 2019 May;20(5):343-350. doi: 10.2459/JCM.0000000000000792.
6
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.扩张型心肌病的自然病史和转归的性别和年龄差异。
Eur J Heart Fail. 2018 Oct;20(10):1392-1400. doi: 10.1002/ejhf.1216. Epub 2018 Jun 3.
7
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.心肌炎患儿的心室重构和存活率优于特发性扩张型心肌病患儿:来自儿科心肌病注册中心的一项结局研究。
Circ Heart Fail. 2010 Nov;3(6):689-97. doi: 10.1161/CIRCHEARTFAILURE.109.902833. Epub 2010 Sep 10.
8
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.过去 30 多年来,托斯卡纳地区特发性扩张型心肌病患者生存率的提高:基于证据的管理的影响。
Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.
9
Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.扩张型心肌病患儿死亡和心脏移植的竞争风险:来自儿科心肌病注册研究的结果。
Circulation. 2011 Aug 16;124(7):814-23. doi: 10.1161/CIRCULATIONAHA.110.973826. Epub 2011 Jul 25.
10
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.卡维地洛治疗肌营养不良继发扩张型心肌病患者的安全性和有效性。
Pediatr Cardiol. 2008 Mar;29(2):343-51. doi: 10.1007/s00246-007-9113-z. Epub 2007 Sep 21.

引用本文的文献

1
A predictive model for left ventricular reverse remodeling after pharmacological therapy in children with recent-onset dilated cardiomyopathy.近期发病的扩张型心肌病患儿药物治疗后左心室逆向重构的预测模型。
PLoS One. 2025 Apr 1;20(4):e0321126. doi: 10.1371/journal.pone.0321126. eCollection 2025.
2
Cardiomyopathy in Children and Adolescents in the Era of Precision Medicine.精准医学时代的儿童和青少年心肌病。
Arq Bras Cardiol. 2024 Sep;121(9):e20230154. doi: 10.36660/abc.20230154.
3
Analysis of clinical features of heart failure in children with cardiomyopathy and improved ejection fraction.
扩张型心肌病患儿心力衰竭的临床特征分析及射血分数改善情况
Transl Pediatr. 2024 Mar 27;13(3):399-407. doi: 10.21037/tp-23-447. Epub 2024 Mar 11.
4
The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study.儿童心肌病的临床特征、遗传基础和生存情况:单中心回顾性研究。
Eur J Pediatr. 2024 Mar;183(3):1389-1401. doi: 10.1007/s00431-023-05358-6. Epub 2024 Jan 2.
5
Non-Cardiac Cause of Death in Selected Group Children with Cardiac Pathology: A Retrospective Single Institute Study.特定心脏病理患儿的非心脏死因:一项单机构回顾性研究
Children (Basel). 2022 Mar 2;9(3):335. doi: 10.3390/children9030335.